Advanced in Hereditary Spastic Paraparesis

Philippe Corcia

Tours, FR 
Advanced in Hereditary Spastic Paraparesis
Tours, FR 
OverviewLocationsClinical Research

Overview

Philippe Corcia practices in Tours, France. Dr. Corcia is rated as an Advanced expert by MediFind in the treatment of Hereditary Spastic Paraparesis. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Hereditary Spastic Paraparesis, Chronic Inflammatory Demyelinating Polyneuropathy, and Gastrostomy.

His clinical research consists of co-authoring 262 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hereditary Spastic Paraparesis.

Gender
Male

Locations

Tours, France
Other Locations
Paris, France
Bron, France
Limoges, France
Val-de-la-haye, France
Lille, France
France
Francois, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Efficacy and Safety of Low-dose IL-2 (Ld-IL-2) as a Treg Enhancer for Controlling Neuro-inflammation in Newly Diagnosed Amyotrophic Lateral Sclerosis (ALS) Patients: A Randomized, Double-blind, Placebo- Controlled, Phase-II Proof of Concept/ Proof of Mechanism Clinical Trial
Efficacy and Safety of Low-dose IL-2 (Ld-IL-2) as a Treg Enhancer for Controlling Neuro-inflammation in Newly Diagnosed Amyotrophic Lateral Sclerosis (ALS) Patients: A Randomized, Double-blind, Placebo- Controlled, Phase-II Proof of Concept/ Proof of Mechanism Clinical Trial
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug
Study Drugs: Riluzole, IL-2
Study Phase: Phase 2
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Biological, Drug, Other
Study Drugs: Vitamin D, Lumbar Puncture, Blood Sampling, Urine Samples
Study Phase: Phase 3
Tear Fluid and Ocular Surface Metabolomics and Lipidomics in Lateral Amyotrophic Sclerosis: a Prospective Comparative Study
Tear Fluid and Ocular Surface Metabolomics and Lipidomics in Lateral Amyotrophic Sclerosis: a Prospective Comparative Study
Enrollment Status: Completed
Publish Date: December 05, 2023
Intervention Type: Other
Study Phase: Not Applicable
New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.
New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.
Enrollment Status: Unknown
Publish Date: November 30, 2023
Intervention Type: Other
Study Phase: Not Applicable
Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS)
Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS)
Enrollment Status: Unknown
Publish Date: July 10, 2023
Intervention Type: Drug
Study Drug: Tauroursodexycholic Acid
Study Phase: Phase 3
Metabolomics and Transcriptomics Approaches to Identify Muscular Biomarkers in Amyotrophic Lateral Sclerosis
Metabolomics and Transcriptomics Approaches to Identify Muscular Biomarkers in Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: April 28, 2021
Intervention Type: Other
Study Phase: Not Applicable
Evaluation of Metabolomic Analysis in Early Diagnosis of ALS
Evaluation of Metabolomic Analysis in Early Diagnosis of ALS
Enrollment Status: Completed
Publish Date: July 17, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Microglial Activation Role In ALS (MARIA)
Microglial Activation Role In ALS (MARIA)
Enrollment Status: Withdrawn
Publish Date: May 31, 2017
Intervention Type: Drug
Study Phase: Early Phase 1
View 7 Less Clinical Trials

262 Total Publications

Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonization.
Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonization.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Corcia's expertise for a condition
ConditionClose
    View All 44 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile